
Last chance! 50% off unlimited learning
Sale ends in
A generated model with a survival endpoint and a cuymulative hazard function estimated using flexible parametric splines. Data for the model were synthetically generated and are based on a dataset to evaulate the use of Sorafenib in HCC akin to the PROSASH model
surv.mod
A model of class 'flezsurvreg':
cumulative baseline hazard parameters
vascular invasion
patient age (centred at 60)
ECOG performance Status
AFP - log scale
albumin
Creatinine - log scale
metastesis
centred age nested within vascular invasion
survival time
censoring indicator
survival time
exapmple outcome for count data
exapmple identifier for mulitple treatment comparisons
Aetiology
Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment. Berhane S, et al., Br J Cancer. 2019 Jul;121(2):117-124